250 ppm F as MFP

DRUG2 trials

Sponsors

Procter and Gamble

Conditions

Caries

Phase 1

Salivary Fluoride Clearance

CompletedNCT06735235

Procter and GambleCaries

Start: 2021-07-14End: 2021-07-29Updated: 2024-12-16

Phase 4

Evaluation of the Fluoride Dose Response Using In Situ Caries Model

CompletedNCT04763044

Procter and GambleCaries

Start: 2021-03-01End: 2021-07-21Updated: 2022-07-19